The global electroretinography market is witnessing strong growth due to the rising prevalence of retinal disorders, increasing adoption of advanced ophthalmic diagnostic technologies, and growing awareness about early eye disease detection. Electroretinography is a critical diagnostic technique that measures the electrical responses of various retinal cell layers, enabling clinicians to detect functional abnormalities that may not be visible through conventional imaging methods.
The electroretinography market was valued at US$ 35.79 million in 2018 and it is projected to reach US$ 62.72 million in 2027; it is expected to grow at a CAGR of 6.7% from 2019 to 2027. This growth trajectory highlights the expanding role of ERG systems in both clinical diagnostics and ophthalmic research.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003514
Key Market Drivers Supporting Growth
Rising Burden of Retinal and Ophthalmic Disorders
One of the most significant drivers of the electroretinography market is the global increase in retinal diseases such as diabetic retinopathy, age-related macular degeneration (AMD), retinitis pigmentosa, and inherited retinal disorders. With diabetes rates rising worldwide, the demand for accurate retinal function assessment tools has strengthened, positioning ERG as a core diagnostic solution.
Growing Geriatric Population
The aging global population is another major growth contributor. Elderly individuals are more susceptible to vision-threatening retinal conditions, creating consistent demand for advanced ophthalmic diagnostics. Electroretinography enables early functional assessment of retinal degeneration before structural damage becomes evident, supporting proactive treatment approaches.
Technological Advancements in ERG Systems
Rapid innovation in ophthalmic devices has resulted in compact, portable, and user-friendly electroretinography systems. Advances such as wireless electrodes, handheld ERG devices, and improved signal processing software are enhancing diagnostic accuracy and patient comfort. These developments are accelerating adoption in hospitals, ophthalmology clinics, and research institutions.
Increasing Focus on Early Diagnosis and Preventive Eye Care
Improved awareness about early diagnosis of eye diseases among patients and healthcare professionals is fueling market growth. Electroretinography plays a crucial role in identifying retinal dysfunction at an early stage, allowing clinicians to implement timely therapeutic intervention and slow disease progression.
Expanding Clinical and Research Applications
Beyond clinical diagnostics, electroretinography is increasingly used in pharmacological research, gene therapy trials, and toxicology studies. The rise in clinical trials for retinal gene and cell therapies has further expanded the application scope of ERG systems, supporting sustained market demand.
Electroretinography Market Segmentation
By Product Type
The market is segmented into full-field ERG, multifocal ERG, and pattern ERG devices. Full-field ERG systems hold a dominant share due to their widespread use in diagnosing generalized retinal dysfunctions. Multifocal and pattern ERG devices are gaining popularity for detecting localized retinal and optic nerve abnormalities.
By End User
Key end users include hospitals, ophthalmic clinics, diagnostic centers, and research laboratories. Hospitals and specialty eye clinics account for a significant market share due to higher patient inflow, availability of skilled ophthalmologists, and advanced diagnostic infrastructure.
By Geography
North America leads the electroretinography market due to advanced healthcare infrastructure, strong adoption of new technologies, and increasing prevalence of retinal diseases. Europe follows closely, while Asia Pacific is expected to witness the fastest growth owing to improving healthcare access, increasing diabetic population, and rising investments in ophthalmic care.
Get Full Copy @ https://www.theinsightpartners.com/buy/TIPRE00003514
Top Players in the Electroretinography Market
Leading companies in the electroretinography market are focusing on innovation, regulatory approvals, and strategic collaborations to strengthen their global presence. Key players include:
- LKC Technologies, Inc.
- Diagnosys LLC
- Roland Consult Stasche & Finger GmbH
- Metrovision (France)
- CSO (Costruzione Strumenti Oftalmici)
- Phoenix Research Labs
These players are investing in product enhancements such as portable ERG devices and advanced software analytics to gain a competitive advantage.
Future Growth Outlook Through 2027
The electroretinography market is expected to maintain steady growth through 2027, supported by expanding clinical applications and continued technological progress. Growing adoption in emerging markets, coupled with increasing research funding in ophthalmology, will further strengthen market expansion. Manufacturers that focus on affordability, portability, and ease of use are likely to gain higher adoption across diverse care settings.
Related Reports @
Ultrasound And Electrosurgical Energy Dissectors Market Size, Share & Growth by 2034
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean German Japanese French Chinese Italian Spanish
